BABY and BABYF Related Headlines
Go Back- Else Nutrition kicks off a Manufacturing Drive in Q2 2026
- Else Nutrition Reports First Quarter 2026 Results Highlighting Significant Improvement in Gross Margin and Reduced Net Loss
- Else Nutrition Commends Trump Administration's Expanded Commitment to Bolstering Infant Formulas Regulation in FY2027
- Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards
- Else Nutrition Surpasses One Million Cans Sold Since Launch
- Else Nutrition Announces Results from Annual General Meeting of Shareholders
- Else Nutrition Plans Canadian Market Relaunch in 2026
- Else Nutrition appoints Natie Zilberberg as chief financial officer
- Else Nutrition Announces Appointment of Natie Zilberberg as Chief Financial Officer
- Else Nutrition Achieves Transformative Operational and Financial Progress in 2025
- ELSE NUTRITION ANNOUNCES FURTHER EXTENSION OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
- Else Nutrition Announces Major Breakthrough: President Trump Signs Pivotal FDA Funding Package that Includes Congressional Directive Streamlining Regulatory Pathway for Non-Dairy, Non-Soy Plant-Based
- Else Nutrition Reports Significant Operational Turnaround in Q3 2025 with Gross Margin Expansion and Cost Reduction
- Else Nutrition Reschedules 2025 Third Quarter Business Update Conference Call
- Else Nutrition Schedules 2025 Third Quarter Business Update Conference Call
- ELSE NUTRITION ANNOUNCES SHARE CONSOLIDATION
- Else Nutrition Reports 2025 Second Quarter Financial Results and Provides Business Update
- Else Nutrition Schedules 2025 Second Quarter Business Update Conference Call
- Else Nutrition Reports 2025 First Quarter Financial Results and Provides Business Update
- Else Nutrition Schedules 2025 First Quarter Business Update Conference Call
- ELSE NUTRITION ANNOUNCES FURTHER EXTENSION OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
- Else Nutrition Applauds Pivotal U.S. Legislative Support for Plant-Based, Non-Soy, Non-Dairy Infant Formula Innovation
- ELSE NUTRITION ANNOUNCES DELAY IN FILING FINANCIAL STATEMENTS AND EXTENSION OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
- Else Nutrition Applauds U.S. Government's Historic Shift in Infant Formula Rules, Unlocking Path to Commercialize the World's First Whole-Food, Dairy-Free Infant Formula
BABY and BABYF Related Press Releases
Go Back- Else Nutrition kicks off a Manufacturing Drive in Q2 2026
- Else Nutrition Reports First Quarter 2026 Results Highlighting Significant Improvement in Gross Margin and Reduced Net Loss
- Else Nutrition Commends Trump Administration's Expanded Commitment to Bolstering Infant Formulas Regulation in FY2027
- Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards
- Else Nutrition Surpasses One Million Cans Sold Since Launch
- Else Nutrition Announces Results from Annual General Meeting of Shareholders
- Else Nutrition Plans Canadian Market Relaunch in 2026
- Else Nutrition Announces Appointment of Natie Zilberberg as Chief Financial Officer
- Else Nutrition Achieves Transformative Operational and Financial Progress in 2025
- ELSE NUTRITION ANNOUNCES FURTHER EXTENSION OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
- Else Nutrition Announces Major Breakthrough: President Trump Signs Pivotal FDA Funding Package that Includes Congressional Directive Streamlining Regulatory Pathway for Non-Dairy, Non-Soy Plant-Based
- Else Nutrition Reports Significant Operational Turnaround in Q3 2025 with Gross Margin Expansion and Cost Reduction
- Else Nutrition Reschedules 2025 Third Quarter Business Update Conference Call
- Else Nutrition Schedules 2025 Third Quarter Business Update Conference Call
- ELSE NUTRITION ANNOUNCES SHARE CONSOLIDATION
- Else Nutrition Reports 2025 Second Quarter Financial Results and Provides Business Update
- Else Nutrition Schedules 2025 Second Quarter Business Update Conference Call
- Else Nutrition Reports 2025 First Quarter Financial Results and Provides Business Update
- Else Nutrition Schedules 2025 First Quarter Business Update Conference Call
- ELSE NUTRITION ANNOUNCES FURTHER EXTENSION OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
- Else Nutrition Applauds Pivotal U.S. Legislative Support for Plant-Based, Non-Soy, Non-Dairy Infant Formula Innovation
- ELSE NUTRITION ANNOUNCES DELAY IN FILING FINANCIAL STATEMENTS AND EXTENSION OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
- Else Nutrition Applauds U.S. Government's Historic Shift in Infant Formula Rules, Unlocking Path to Commercialize the World's First Whole-Food, Dairy-Free Infant Formula
